Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$29.8 - $40.3 $319,247 - $431,733
-10,713 Reduced 23.83%
34,234 $1.19 Million
Q2 2023

Aug 14, 2023

BUY
$28.53 - $39.55 $748,883 - $1.04 Million
26,249 Added 140.38%
44,947 $1.47 Million
Q1 2023

May 15, 2023

BUY
$29.51 - $46.65 $49,665 - $78,511
1,683 Added 9.89%
18,698 $626,000
Q4 2022

Feb 14, 2023

BUY
$24.16 - $36.38 $411,082 - $619,005
17,015 New
17,015 $557,000

Others Institutions Holding VTYX

About Ventyx Biosciences, Inc.


  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $128M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.